首站-论文投稿智能助手
典型文献
Medication Rule Analysis of the Diagnosis and Treatment Programs of Chinese Medicine for the Prevention and Treatment of COVID-19 in China
文献摘要:
Objectives:To summarize the measures and rules of Chinese medicine(CM)and provide reference for clinical application in the prevention and treatment of coronavirus disease(COVID-19).Methods:The data source was from CM COVID-19 prevention and treatment programs on government websites and official media websites of the different provinces and cities.The search lasted from December 8,2019 to March 10,2020.Main variables were medication frequency and combinations of medicines.Cluster analysis and complex network analysis were used by prevention and treatment stage and by area.Results:Among 27 CM diagnosis and treatment plans,203 therapeutic prescriptions were enrolled,of which the top 4 herbs were:Radix glycyrrhizae,Semen armeniacae amarum,Herba ephedrae,and Herba agastachis,respectively.The core combinations were Herba ephedrae and Semen armeniacae amarum.Forty-eight preventive formulae were identified.Ten herbs,including Radix Astragali seu hedysari,Radix glycyrrhizae,Radix saposhnikoviae,Flos Ionicerae,etc.were most frequently used.The core prescription of CM compatibility was Radix astragali seu hedysari,Radix glycyrrhizae,and Radix saposhnikoviae,which is the main component of Yu Ping Feng San.There were 45 prevention and treatment prescriptions in East China;the most used CM was Radix glycyrrhizae,Herba agastachis,Pericarpium citri reticulatae,and Gypsum fibrosum.Fifty prescriptions were identified in North China.According to CM analyses,Herba agastachis,Semen armeniacae amarum,Herba ephedrae,and Poria were most frequently used.Conclusions:CM for COVID-19 prevention mainly focuses on improving human immunity;for treatment,prescription focuses on clearing the lungs and removing dampness.Prescriptions vary with regions,perhaps due to climatic and environmental differences,which help clinicians to quickly make CM plans and treat patients according to clinical status,further minimizing resource wastage.
文献关键词:
作者姓名:
JI Xin-yu;MA Yan;SHI Shuai;LIU Si-hong;TONG Lin;LYU Cheng;ZHANG Hua-min;WANG Yan-ping
作者机构:
Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing(100700),China;Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing(100053),China;Institute of Information on Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing(100700),China;Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing(100700),China
引用格式:
[1]JI Xin-yu;MA Yan;SHI Shuai;LIU Si-hong;TONG Lin;LYU Cheng;ZHANG Hua-min;WANG Yan-ping-.Medication Rule Analysis of the Diagnosis and Treatment Programs of Chinese Medicine for the Prevention and Treatment of COVID-19 in China)[J].中国结合医学杂志(英文版),2022(09):779-784
A类:
glycyrrhizae,armeniacae,amarum,ephedrae,agastachis,hedysari,saposhnikoviae,Ionicerae,astragali,reticulatae,Gypsum,fibrosum,Prescriptions
B类:
Medication,Rule,Analysis,Diagnosis,Treatment,Programs,Chinese,Medicine,Prevention,China,Objectives,To,summarize,measures,rules,CM,provide,reference,clinical,application,prevention,treatment,coronavirus,disease,Methods,data,from,programs,government,websites,official,media,different,provinces,cities,search,lasted,December,March,Main,variables,were,medication,frequency,combinations,medicines,Cluster,analysis,complex,network,used,by,area,Results,Among,diagnosis,plans,therapeutic,prescriptions,enrolled,which,top,herbs,Radix,Semen,Herba,respectively,core,Forty,eight,preventive,formulae,identified,Ten,including,Astragali,seu,Flos,etc,most,frequently,compatibility,component,Yu,Ping,Feng,San,There,East,Pericarpium,citri,Fifty,North,According,analyses,Poria,Conclusions,mainly,focuses,improving,human,immunity,clearing,lungs,removing,dampness,vary,regions,perhaps,due,climatic,environmental,differences,help,clinicians,quickly,make,patients,according,status,further,minimizing,resource,wastage
AB值:
0.459739
相似文献
A Case Series of Olfactory Dysfunction in Imported COVID-19 Patients: A 12-Month Follow-Up Study
WANG Ni;YANG Ming Bo;YANG Pu Ye;CHEN Ren Bo;HUANG Fei;SHI Nan Nan;MA Yan;ZHANG Yan;XU You;LIU Si Hong;LU Heng Yi;FU Qing Qing;FAN Yi Pin;KAN Hong Min;WANG Xiao Hong;GUO Ya Ling-National Center for Tuberculosis Control and Prevention,Chinese Center for Disease Control and Prevention, Beijing 102206,China;Hepatology Department of TCM,Xi'an NO.8 Hospital,Xi'an 710061,Shaanxi,China;Department of Integrated Chinese and Western Medicine,Xi'an NO.8 Hospital,Xi'an 710061,Shaanxi,China;Department of Infection,Xi'an NO.8 Hospital,Xi'an 710061,Shaanxi,China;Institute of Information on Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700, China
Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma:Integrating Bioinformatics and Clinical Analyses
Xing WEI;Qing-mei ZHANG;Chang LIU;Song WU;Wei-xia NONG;Ying-ying GE;Li-na LIN;Feng LI;Xiao-xun XIE;Bin LUO-Department of Histology and Embryology,School of Pre-clinical Medicine,Guangxi Medical University,Nanning 530021,China;Department of Neurology,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Central Laboratory of Pre-Clinical Medicine(Key Laboratory of Guangxi Colleges and Universities),Guangxi Medical University,Nanning 530021,China;Department of Neurosurgery,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumor(Guangxi Medical University),Ministry of Education,Nanning 530021,China
Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
Wu Zheng;Tan Fengwei;Yang Zhuoyu;Wang Fei;Cao Wei;Qin Chao;Dong Xuesi;Zheng Yadi;Luo Zilin;Zhao Liang;Yu Yiwen;Xu Yongjie;Ren Jiansong;Shi Jufang;Chen Hongda;Li Jiang;Tang Wei;Shen Sipeng;Wu Ning;Chen Wanqing;Li Ni;He Jie-Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Key Laboratory of Cancer Data Science, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;PET-CT Center, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
A Predictive Nomogram for Predicting Improved Clinical Outcome Probability in Patients with COVID-19 in Zhejiang Province,China
Jiaojiao Xie;Ding Shi;Mingyang Bao;Xiaoyi Hu;Wenrui Wu;Jifang Sheng;Kaijin Xu;Qing Wang;Jingjing Wu;Kaicen Wang;Daiqiong Fang;Yating Li;Lanjuan Li-State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China;State Key Laboratory of Genetic Engineering,Institute of Biostatistics,School of Life Sciences,Fudan University,Shanghai 200433,China;Division of Hepatobiliary and Pancreatic Surgery,Department of Surgery,Key Lab of Combined Multi-organ Transplantation of the Ministry of Health,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China;Division of of Endocrinology and Metabolism,Department of Internal Medicine System,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China
Effects of Medicines and Supplements on Spontaneous Pregnancy and Semen Parameters in Male Infertility:A Systematic Review Update and Network Meta-Analysis
Jian Li;Qi Wu;Ernest Hung Yu Ng;Ben Willem J.Mol;Xiao Ke Wu;Chi Chiu Wang-Department of Obstetrics and Gynecology,First Affiliated Hospital,Heilongjiang University of Chinese Medicine,Harbin 150040,China;Department of Obstetrics and Gynecology,The Affiliated Hospital of Gui Zhou Medical University,Guiyang 550004,China;Department of Obstetrics and Gynaecology,Prince of Wales Hospital,The Chinese University of Hong Kong,Hong Kong 999077,China;Department of Obstetrics and Gynecology,Obstetrics and Gynecology Hospital,Fudan University,Shanghai 30009,China;Department of Obstetrics and Gynaecology,Queen Mary Hospital,The University of Hong Kong,Hong Kong 999077,China;Department of Obstetrics and Gynaecology,Monash University,Clayton,VIC 3168,Australia;Heilongjiang Provincial Hospital,Harbin Institute of Technology,Harbin 150036,China;Reproduction and Development Laboratory,Li Ka Shing Institute of Health Sciences,The Chinese University of Hong Kong,Hong Kong 999077,China;School of Biomedical Sciences,The Chinese University of Hong Kong,Hong Kong 999077,China;The Chinese University of Hong Kong-Sichuan University Joint Laboratory of Reproductive Medicine,Hong Kong 999077,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。